Bormioli Pharma
Bormioli Pharma is an Italian pharmaceutical primary packaging manufacturer — wholly-owned by Gerresheimer AG — producing glass and plastic containers, medical devices, and dual chamber reconstitution kits for global pharmaceutical and biotech manufacturers.
- Company typePrivate
- Founded1825
- HeadquartersMilan, Italy
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bormioli Pharma does
Bormioli Pharma S.p.A. is a pharmaceutical primary packaging manufacturer headquartered in Parma, Italy, with a registered office in Milan and operating subsidiaries in France, the United States (Delaware), Germany, and China (Shanghai). The company is a wholly-owned subsidiary of Gerresheimer AG, a Düsseldorf-based multinational that distributes the portfolio globally as part of its pharma and biotech systems offering. Bormioli Pharma produces glass containers (Flint I, Amber I, Flint III, Amber III) and plastic containers (PP, HDPE, LDPE, PE) for injection, oral solid, oral liquid, chromatography, and reagent applications, alongside medical devices such as measuring cups (AF0975 series) and dual chamber reconstitution kits marketed under the AccuRec, ActiveRec, and EasyRec sub-brands, with ActiveRec incorporating proprietary DRIEX integrated technology. Manufacturing is qualified to ISO 9001, ISO 15378 (GMP for pharma primary packaging), ISO 13485 (medical devices), ISO 45001, and ISO 14001, with medical device products compliant with EU Regulation 2017/745.
The company sells exclusively B2B to pharmaceutical and biotechnology manufacturers through a quote-based enterprise field sales motion, with pricing negotiated per multi-year contract based on volume and customization requirements; no retail channel or public pricing exists. Customers engage via the company's website to scope requirements, with a wishlist-driven inquiry flow feeding directly to the sales team. Sub-brand and SKU breadth — 685+ products — supports both standardized catalog orders and engineered custom packaging programs. Distribution is executed through Gerresheimer's global sales network rather than independent channels, embedding Bormioli Pharma inside the parent's compliance framework (Italian Legislative Decree 231/2001, EU Whistleblowing Directive 2019/1937, anti-corruption, antitrust, Code of Ethics) and ESG policy aligned with UN Agenda 2030 SDGs. The combined manufacturing capability, regulatory depth, and Gerresheimer-parent distribution are the structural basis of the company's positioning in pharma primary packaging.
Bormioli Pharma firmographics
Firmographics- Name
- Bormioli Pharma
- Legal name
- Bormioli Pharma S.p.A.
- Website
- https://bormiolipharma.com
- Company type
- Private
- Founded year
- 1825
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Bormioli Pharma is an Italian pharmaceutical primary packaging manufacturer — wholly-owned by Gerresheimer AG — producing glass and plastic containers, medical devices, and dual chamber reconstitution kits for global pharmaceutical and biotech manufacturers.
- Ownership category
- akta.pro rank
Bormioli Pharma industry classification
Industry- Product category
- Pharmaceutical Primary Packaging
- NAICS
- Glass Container Manufacturing (327213), Plastics Bottle Manufacturing (326160)
- SIC
- Glass Containers (3221), Glass Products, Made Of Purchased Glass (3231), Miscellaneous Plastics Products (3080)
- akta.pro primary industry
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)
- akta.pro secondary industries
- Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB), Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)
Keywords
Where Bormioli Pharma is headquartered
LocationHeadquarters
- HQ city
- Milan
- HQ country
- Italy
- HQ region
- Europe
Offices6 records
Markets served
Bormioli Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Primary Packaging Sales: Direct sale of pharmaceutical packaging products including glass containers, plastic containers, dual chamber kits, medical devices, and pharmaceutical dispensers to pharmaceutical and biotech companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based enterprise pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Bormioli Pharma product offering
Product offeringCore offering
Bormioli Pharma manufactures pharmaceutical primary packaging including glass containers (Flint and Amber Types I and III) and plastic containers (PP, HDPE, LDPE, PE) for injection, oral solid, chromatography, and reagent applications. The company also produces dual chamber reconstitution kits (AccuRec, ActiveRec, EasyRec) for oral pharmaceuticals and medical devices such as measuring cups and pharmaceutical dispensers. Products are sold directly to pharmaceutical and biotech manufacturers as part of the Gerresheimer Group portfolio.
Product overview
Bormioli Pharma is a pharmaceutical primary packaging manufacturer offering a comprehensive portfolio of 685 products integrated into the Gerresheimer Group. The product range includes glass and plastic containers for various routes of administration (Injection, Oral Solid, Chromatography, Reagents) available in Flint and Amber glass types, medical devices such as measuring cups (AF0975 series) for oral liquid and oral reconstitution, and dual chamber reconstitution kits (AccuRec and ActiveRec systems) for pharmaceutical preparations. All products are designed for the pharma and biotech industry with focus on safe and convenient medicine administration.
Differentiator
Problem solved
Functional benefit
Brands
- AccuRec: Dual chamber kit product line for oral reconstitution applications
- ActiveRec
- EasyRec
Products and services
- Pharmaceutical Containers Pharmaceutical glass and plastic containers available in Flint and Amber glass types (Type I and Type III) for various routes of administration including Injection, Oral Solid, Chromatography, and Reagents. Designed for pharmaceutical and biotech manufacturers requiring primary packaging.
- AF0975 OL Measuring Cup Medical device measuring cup for oral liquid administration, made of PP plastic with PFP 28 screw neck finish. Features level marks from 2.5ml to 10ml. EU Regulation 2017/745 compliant.
- AF0975 OR Measuring Cup Medical device measuring cup for oral reconstitution, made of PP plastic with PFP 28 screw neck finish. Features level marks from 2.5ml to 10ml. EU Regulation 2017/745 compliant.
- AccuRec Kit (4cc) Dual chamber kit for oral reconstitution composed of Cap AM1586, Plug AM1583, and Plunger AM1587. Available in 4cc nominal capacity using PP, HDPE, and LDPE materials. Enables separate storage of powder and liquid until time of administration.
- ActiveRec Kit 0.5cc Dual chamber kit for oral reconstitution using the EasyRec system. Composition includes Cap AM1299, Plug AM1376, and Plunger AM1567. Features PP, HDPE, LDPE, and DRIEX materials.
- ActiveRec Kit 0.8cc Dual chamber kit for oral reconstitution using the EasyRec system. Composition includes Cap AM1299, Plug AM1376, and Plunger AM1599. Features PP, HDPE, LDPE, and DRIEX materials.
Companies that use Bormioli Pharma
Customer profileSegments2 records
Ideal customer profiles2 records
Bormioli Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Bormioli Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Gerresheimer GroupcoreBormioli Pharma is part of the Gerresheimer Group, a global provider of systems and solutions for the pharma and biotech industry. Bormioli Pharma's products are integrated into Gerresheimer's portfolio, contributing to the most complete and high-quality offering in the pharmaceutical packaging industry. Gerresheimer AG, headquartered in Düsseldorf, Germany, sets overarching compliance framework and organizational standards for its global operations.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Bormioli Pharma competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Bormioli Pharma social profiles
Digital presenceBormioli Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bormioli Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Bormioli Pharma subsidiaries and ownership
Company hierarchySubsidiaries4 records
Bormioli Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bormioli Pharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bormioli Pharma
What does Bormioli Pharma do?
Bormioli Pharma manufactures pharmaceutical primary packaging including glass containers (Flint and Amber Types I and III) and plastic containers (PP, HDPE, LDPE, PE) for injection, oral solid, chromatography, and reagent applications. The company also produces dual chamber reconstitution kits (AccuRec, ActiveRec, EasyRec) for oral pharmaceuticals and medical devices such as measuring cups and pharmaceutical dispensers. Products are sold directly to pharmaceutical and biotech manufacturers as part of the Gerresheimer Group portfolio.
Is Bormioli Pharma a public or private company?
Bormioli Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Bormioli Pharma founded?
Bormioli Pharma was founded in 1825. It employs 1,001 to 5,000 people.
Where is Bormioli Pharma based?
Bormioli Pharma is headquartered in Milan, Italy, in the Europe region.
How does Bormioli Pharma make money?
One revenue line is on record: pharmaceutical Primary Packaging Sales.
Does Bormioli Pharma have an API?
No public API is recorded for Bormioli Pharma.
What industry is Bormioli Pharma in?
Bormioli Pharma's product category is Pharmaceutical Primary Packaging. Its primary akta.pro industry code is IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules), with a secondary code of IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes). Its NAICS code is 327213 and its SIC code is 3221.